MedPath

Longitudinal Study for the Development of Innovative Wearable Tools for Foetal Wellbeing Monitoring

Not Applicable
Completed
Conditions
Foetal Wellbeing
Interventions
Device: TMSi Porti
Device: Bloomlife sensor
Registration Number
NCT03969433
Lead Sponsor
Bloom Technologies
Brief Summary

The purpose of this study is to support the development of a new generation of the Bloomlife sensor, enabling continuous monitoring of foetal wellbeing.

Data is collected in four Phases, with different experimental setups. Recordings with investigational and reference devices are performed on the subjects, at different gestational ages.

The collected data is used for developing algorithms for the extraction of parameters descriptive of foetal wellbeing.

Clinical information related to subjects' pregnancy and foetal health is also collected.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
231
Inclusion Criteria
  • Pregnant
  • Gestational age of at least 20 weeks
  • Singleton pregnancy
  • Willingness to participate in the study
Exclusion Criteria
  • Multiple pregnancy
  • Implanted pacemaker or any other implanted electrical device
  • History of allergies to silicone-based adhesives

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Phase ITMSi PortiData collections are performed with TMSi Porti system and CTG (reference)
Phases II-III-IVBloomlife sensorData collections are performed with the Bloomlife sensor and CTG (reference)
Primary Outcome Measures
NameTimeMethod
Accuracy and reliability in the detection of foetal movementsThroughout the subject's participation in the study, from inclusion until delivery

Foetal movements are detected from the collected sensor data and compared to the reference

Accuracy and reliability in the detection of foetal heart rateThroughout the subject's participation in the study, from inclusion until delivery

Foetal heart rate is extracted from the collected electrophysiological data and compared to the reference

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ziekenhuis Oost-Limburg

🇧🇪

Genk, Limburg, Belgium

© Copyright 2025. All Rights Reserved by MedPath